{"id":"https://openalex.org/W2164101931","doi":"https://doi.org/10.1192/bjp.bp.110.083766","title":"The rise and fall of the atypical antipsychotics","display_name":"The rise and fall of the atypical antipsychotics","alternate_titles":[],"publication_year":2011,"publication_date":"2011-10-01","ids":{"openalex":"https://openalex.org/W2164101931","doi":"https://doi.org/10.1192/bjp.bp.110.083766","mag":"2164101931","pmid":"https://pubmed.ncbi.nlm.nih.gov/22187726"},"language":"en","primary_location":{"id":"doi:10.1192/bjp.bp.110.083766","doi":"https://doi.org/10.1192/bjp.bp.110.083766","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.110.083766","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F60F5CEA618855E5FB66E6A51A56A122/S0007125000258236a.pdf/div-class-title-the-rise-and-fall-of-the-atypical-antipsychotics-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2164101931"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F60F5CEA618855E5FB66E6A51A56A122/S0007125000258236a.pdf/div-class-title-the-rise-and-fall-of-the-atypical-antipsychotics-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103062976","display_name":"Tim Kendall","orcid":"https://orcid.org/0000-0003-3825-3022","observed_orcids":["https://orcid.org/0000-0003-3825-3022"]},"institutions":[{"id":"https://openalex.org/I68870429","display_name":"Royal College of Psychiatrists","ror":"https://ror.org/04xy18872","country_code":"GB","type":"education","lineage":["https://openalex.org/I68870429"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tim Kendall","raw_affiliation_strings":["National Collaborating Centre for Mental Health, Royal College of Psychiatrists' Research Unit, 4th Floor, Standon House, 21 Mansell Street, London E1 8AA, UK. Email:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Collaborating Centre for Mental Health, Royal College of Psychiatrists' Research Unit, 4th Floor, Standon House, 21 Mansell Street, London E1 8AA, UK. Email:","institution_ids":["https://openalex.org/I68870429"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103062976"],"corresponding_institution_ids":["https://openalex.org/I68870429"],"apc_list":{"value":4920,"currency":"USD","value_usd":4920},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"199","issue":"4","first_page":"266","last_page":"268"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9950000047683716},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7960000038146973},{"id":"https://openalex.org/keywords/pharmaceutical-marketing","display_name":"pharmaceutical marketing","score":0.75},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C204017024","wikidata":"https://www.wikidata.org/wiki/Q485446","display_name":"Optimism","level":2,"score":0.7727596759796143},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6075130701065063},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5816992521286011},{"id":"https://openalex.org/C2984752397","wikidata":"https://www.wikidata.org/wiki/Q3259956","display_name":"Primary care","level":2,"score":0.5066081285476685},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41866257786750793},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40119123458862305},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.27098751068115234},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.22924676537513733}],"mesh":[{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1192/bjp.bp.110.083766","doi":"https://doi.org/10.1192/bjp.bp.110.083766","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.110.083766","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F60F5CEA618855E5FB66E6A51A56A122/S0007125000258236a.pdf/div-class-title-the-rise-and-fall-of-the-atypical-antipsychotics-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:22187726","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22187726","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of psychiatry : the journal of mental science","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1192/bjp.bp.110.083766","doi":"https://doi.org/10.1192/bjp.bp.110.083766","is_oa":true,"landing_page_url":"https://doi.org/10.1192/bjp.bp.110.083766","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F60F5CEA618855E5FB66E6A51A56A122/S0007125000258236a.pdf/div-class-title-the-rise-and-fall-of-the-atypical-antipsychotics-div.pdf","source":{"id":"https://openalex.org/S127936299","display_name":"The British Journal of Psychiatry","issn_l":"0007-1250","issn":["0007-1250","1472-1465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2164101931.pdf","grobid_xml":"https://content.openalex.org/works/W2164101931.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1573555860","https://openalex.org/W1954888178","https://openalex.org/W1983990304","https://openalex.org/W1994840924","https://openalex.org/W2045242021","https://openalex.org/W2058132385","https://openalex.org/W2060417841","https://openalex.org/W2096635847","https://openalex.org/W2098631889","https://openalex.org/W2103345048","https://openalex.org/W2109196233","https://openalex.org/W2116153150","https://openalex.org/W2152770536","https://openalex.org/W2159155203","https://openalex.org/W4214747479","https://openalex.org/W7038232279"],"related_works":["https://openalex.org/W2500998500","https://openalex.org/W2010598606","https://openalex.org/W4229668389","https://openalex.org/W2029465348","https://openalex.org/W4380488572","https://openalex.org/W2264219951","https://openalex.org/W2033535996","https://openalex.org/W2187194777","https://openalex.org/W2330706777","https://openalex.org/W2395613622"],"abstract_inverted_index":{"Summary":[0],"The":[1],"antipsychotics":[2,24],"brought":[3],"hope":[4],"and":[5,11,33],"optimism":[6],"to":[7,12,30],"people":[8],"with":[9],"schizophrenia":[10],"those":[13],"who":[14],"care":[15],"for":[16,51],"them.":[17],"There":[18],"have":[19],"been":[20],"successive":[21],"classes":[22,49],"of":[23,46],"used":[25],"by":[26],"the":[27,43],"pharmaceutical":[28],"industry":[29],"persuade":[31],"doctors":[32],"patients":[34],"that":[35,42],"\u2018new\u2019":[36],"is":[37,40,50,54],"better.":[38],"Evidence":[39],"growing":[41],"primary":[44],"purpose":[45],"these":[47,59],"fabricated":[48],"marketing.":[52],"It":[53],"time":[55],"we":[56],"stopped":[57],"using":[58],"expensive":[60],"labels":[61],"\u2013":[62],"they":[63],"are":[64],"all":[65],"just":[66],"antipsychotics.":[67]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2164101931","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
